Table 2 Primary and secondary outcomes before and after the intervention
| Â | Pre-intervention | Post-intervention | ||||
|---|---|---|---|---|---|---|
Empagliflozin | Linagliptin | P-value | Empagliflozin | Linagliptin | P-value | |
Albuminuria (mg/24Â h) | 141.9 (171.76) | 67.28 (38.8) | 0.03 | 53(84.57) | 66.4 (67.72) | 0.739 |
eGFR (mL/min) | 74.9 (17.05) | 69.76 (18.7) | 0.271 | 76.13 (15.95) | 69.18 (17.56) | 0.114 |
FBS (mg/dL) | 184.4 (52.31) | 148.9 (43.3) | 0.006 | 143.33 (56.8) | 134.16 (57.53) | 0.46 |
HbA1C (mmol/mol) | 8.99 (1.42) | 8.14 (0.9) | 0.015 | 8.18 (1.39) | 7.66 (1.57) | 0.09 |